Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 57, Issue 3, 2012, Pages 820-821

  Ghosh, Souvik ^a   Duseja, Ajay ^a   Dhiman, Radha Krishan ^a   Chawla, Yogesh Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatitis C virus; Peginterferon alfa 2b; Tongue hyperpigmentation

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA; ALPHA INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERPIGMENTATION; HYPERTRANSAMINASEMIA; PRIORITY JOURNAL; TONGUE DISEASE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; TONGUE;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERPIGMENTATION; INTERFERON-ALPHA; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; TONGUE; TONGUE DISEASES;

EID: 84859488693     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1914-5     Document Type: Article

References (10)

1. Doutre MS. Hepatitis C virus-related skin diseases. Arch Dermatol. 1999;135:1401-1403.
2. Dalekos GN, Christodoulou D, Kitis KG, Zervou EK, Hatzis J, Tsianos EV. A prospective evaluation of dermatological sideeffects during alfa-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol. 1998;10:933-939. (Pubitemid 28561287)
3. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela C. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol. 1999;135:1000-1001. (Pubitemid 29382455)
4. Gurguta C, Kauer C, Bergholz U, Formann E, Steindl-Munda P, Ferenci P. Tongue and skin hyperpigmentation during PEGinterferon-alpha/ribavirin therapy in dark skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol. 2006; 101:197-198. (Pubitemid 43381730)
5. Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a Caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol. 2007;102:1334-1335. (Pubitemid 46802016)
6. Sood A, Midha V, Bansal M, Goyal A, Sharma N. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol. 2006;25:324. (Pubitemid 46708845)
7. Dell'Isola S, Ialungo AM, Starnini G, Roselli P, Ghittoni G, Caturelli E. A surprising hyperpigmentation of the gums and tongue. Gut. 2008;57:1697-1727.
8. Fernandez A, Vasquez S, Rodriguez-Gonzalez L. Tongue hyperpigmentation resulting from peginterferon alpha-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol. 2008;22:1389-1391.
9. Willems M, Munte K, Vrolijk JM, et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol. 2003;149:390-394. (Pubitemid 37100268)
10. Mooy WJ, Krausz T. Biopsy pathology of melanocyte disorders. 1st ed. London: Chapman and Hall; 1992:2.